Bicycle Therapeutics Statistics

Total Valuation

BCYC has a market cap or net worth of $577.58 million. The enterprise value is -$207.07 million.

Market Cap	577.58M
Enterprise Value	-207.07M

Important Dates

The last earnings date was Thursday, May 1, 2025, before market open.

Earnings Date	May 1, 2025
Ex-Dividend Date	n/a

Share Statistics

BCYC has 69.25 million shares outstanding. The number of shares has increased by 67.48% in one year.

Current Share Class	n/a
Shares Outstanding	69.25M
Shares Change (YoY)	+67.48%
Shares Change (QoQ)	+0.21%
Owned by Insiders (%)	0.98%
Owned by Institutions (%)	42.21%
Float	n/a

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	21.03
Forward PS	17.66
PB Ratio	0.78
P/TBV Ratio	0.78
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 14.86, with a Debt / Equity ratio of 0.01.

Current Ratio	14.86
Quick Ratio	14.57
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-258.71

Financial Efficiency

Return on equity (ROE) is -37.07% and return on invested capital (ROIC) is -27.03%.

Return on Equity (ROE)	-37.07%
Return on Assets (ROA)	-21.69%
Return on Invested Capital (ROIC)	-27.03%
Return on Capital Employed (ROCE)	-30.06%
Revenue Per Employee	$84,334
Profits Per Employee	-$666,302
Employee Count	305
Asset Turnover	0.04
Inventory Turnover	n/a

Taxes

Income Tax	-5.50M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -64.69% in the last 52 weeks. The beta is 1.60, so BCYC's price volatility has been higher than the market average.

Beta (5Y)	1.60
52-Week Price Change	-64.69%
50-Day Moving Average	8.66
200-Day Moving Average	17.13
Relative Strength Index (RSI)	49.89
Average Volume (20 Days)	406,143

Short Selling Information

Short Interest	3.13M
Short Previous Month	4.30M
Short % of Shares Out	8.63%
Short % of Float	n/a
Short Ratio (days to cover)	7.25

Income Statement

In the last 12 months, BCYC had revenue of $25.72 million and -$203.22 million in losses. Loss per share was -$3.13.

Revenue	25.72M
Gross Profit	-171.57M
Operating Income	-248.36M
Pretax Income	-163.02M
Net Income	-203.22M
EBITDA	-241.21M
EBIT	-248.36M
Loss Per Share	-$3.13

Full Income Statement

Balance Sheet

The company has $792.97 million in cash and $8.33 million in debt, giving a net cash position of $784.65 million or $11.33 per share.

Cash & Cash Equivalents	792.97M
Total Debt	8.33M
Net Cash	784.65M
Net Cash Per Share	$11.33
Equity (Book Value)	740.33M
Book Value Per Share	10.70
Working Capital	798.46M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$180.23 million and capital expenditures -$1.83 million, giving a free cash flow of -$182.05 million.

Operating Cash Flow	-180.23M
Capital Expenditures	-1.83M
Free Cash Flow	-182.05M
FCF Per Share	-$2.63

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	-965.55%
Pretax Margin	-811.46%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

BCYC does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-67.48%
Shareholder Yield	n/a
Earnings Yield	-35.19%
FCF Yield	-31.52%

Analyst Forecast

The average price target for BCYC is $25.00, which is 199.76% higher than the current price. The consensus rating is "Buy".

Price Target	$25.00
Price Target Difference	199.76%
Analyst Consensus	Buy
Analyst Count	10
Revenue Growth Forecast (5Y)	72.50%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

BCYC has an Altman Z-Score of 4.32 and a Piotroski F-Score of 2.

Altman Z-Score	4.32
Piotroski F-Score	2